摘要
甲状腺癌(TC)是内分泌系统多见的恶性肿瘤。燕树勋教授认为甲状腺疾病,包括TC及TC术后疾病,无论是从经脉循行还是生理病理变化来说,都与肝密切相关。燕教授认为TC术后常见病因有七情致病、手术创伤、碘及甲状腺激素等,并重视情志因素在疾病演变过程中肝气、肝火、肝阳的区别,并提出肝气郁结、肝火旺盛、肝阳上亢为TC及TC术后早期患者的主要病机。本文通过总结燕树勋教授从肝经论治及结合中医药治疗TC术后的经验,来对这一疾病进行探析。
Thyroid cancer(TC) is a common malignancy tumor of the endocrine system. Professor Yan Shuxun believes that thyroid diseases, including TC and postoperative TC diseases, are closely related to the liver, whether they are from the meridian circulation or physiological and pathological changes. Professor Yan believes that the common causes of postoperative TC include seven-pathogenic diseases, surgical trauma, iodine and thyroid hormones. He also attaches importance to the differences in the emotional factors of liver qi, liver fire, and liver yang in the process of disease evolution, and proposes that stagnation of liver qi, exuberance of liver fire, and upper hyperactivity of liver yang are the main pathogenesis of early patients in TC and postoperative TC. This article analyzes the disease by summarizing Professor Yan Shuxun′s experience in the treatment of TC from the treatment of liver diseases and combined with Chinese medicine.
作者
韩青青
王颖
段飞
王泽瑾
郭盼盼
燕苗苗
陈亚琳
闫诏
燕树勋
HAN Qingqing;WANG Ying;DUAN Fei;WANG Zejin;GUO Panpan;YAN Miaomiao;CHEN Yalin;YAN Zhao;YAN Shuxun(Ward 2,Department of Endocriology,the First Affiliated Hospital of He′nan University of Chinese Medicine,He′nan Province,Zhengzhou 450000,China;Department of Geriatric Cardiology,the First Affiliated Hospital of Zhengzhou University,He′nan Province,Zhengzhou 450000,China;Medical College,Hebei University of Engineering,Hebei Province,Handan 056038,China;College of Acupuncture and Massage,He′nan University of Chinese Medicine,He′nan Province,Zhengzhou 450046,China;He′nan Workstation,Inheritance Studio of Chen′s Goiter Academic School in Hubei,State Administration of Traditional Chinese Medicine,He′nan Province,Zhengzhou 450000,China)
出处
《中国医药导报》
CAS
2019年第25期138-141,共4页
China Medical Herald
基金
河南省科技创新杰出青年项目(174100510022)
关键词
甲状腺癌
燕树勋
从肝论治
Thyroid cancer
Yan Shuxun
Treatment from the liver
